Welsh N. “Are off-Target Effects of Imatinib the Key to Improving Beta-Cell Function in Diabetes?”. Upsala Journal of Medical Sciences, vol. 127, no. 1, Sept. 2022, doi:10.48101/ujms.v127.8841.